We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Our top pick for
US stocks
Our top pick for
ETF investing
Our top pick for
Overall broker
| 52-week range | $0.32 - $0.77 |
|---|---|
| 50-day moving average | $0.4329 |
| 200-day moving average | $0.5066 |
| Target price | $0.24 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.024 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$0.46
| 1 week (2021-10-18) | 12.20% |
|---|---|
| 1 month (2021-09-24) | 6.98% |
| 3 months (2021-07-23) | -3.16% |
| 6 months (2021-04-23) | -22.03% |
| 1 year (2020-10-23) | 22.67% |
|---|---|
| 2 years (2019-10-25) | 820.00% |
| 3 years (2018-10-25) | 313.30% |
| 5 years (2016-10-21) | 98.36% |
| Revenue TTM | $874,977 |
|---|---|
| Gross profit TTM | $72,213 |
| Return on assets TTM | -57.11% |
| Return on equity TTM | -232.23% |
| Profit margin | 0% |
| Book value | 0.012 |
| Market capitalisation | $779.5 million |
TTM: trailing 12 months
We're not expecting BrainChip Holdings to pay a dividend over the next 12 months.
Over the last 12 months, BrainChip Holdings's shares have ranged in value from as little as $0.32 up to $0.77. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while BrainChip Holdings's is 1.9268. This would suggest that BrainChip Holdings's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
BrainChip Holdings Ltd develops software and hardware accelerated solutions for artificial intelligence (AI) and machine learning applications in North America, Europe, the Middle East, and Asia. It offers Akida Development Environment, a machine learning framework for creating, training, and testing neural networks, as well as supporting the development of systems for edge AI on its Akida event domain neural processor; and Akida Neuromorphic Processor to provide a ultra-low power and fast AI Edge Network for vision, audio, olfactory, and smart transducer applications. The company also provides Akida Neuromorphic System-on-Chip, an integrated solution for Edge AI device and systems. Its products are used in various applications, such as automotive and cybersecurity. The company has a research collaboration with Biotome Pty Ltd for SARS-CoV-2 antibody detection. BrainChip Holdings Ltd was incorporated in 2011 and is based in Sydney, Australia.
Shares in the wealth management giant have been largely stable in the last 6 months.
Everything we know about the Judo Capital Holdings IPO, plus information on how to buy in.
Everything we know about the Alloggio Group IPO, plus information on how to buy in.
Everything we know about the Larvotto Resources IPO, plus information on how to buy in.
Everything we know about the Vulcan Steel IPO, plus information on how to buy in.
Everything we know about the Artrya IPO, plus information on how to buy in.
Everything we know about the 8 Au IPO, plus information on how to buy in.
Everything we know about the Radiopharm Theranostics IPO, plus information on how to buy in.
The online retailer’s shares have lost more than half their value in the last 12 months.
Everything we know about the GQG Partners IPO, plus information on how to buy in.
